Cargando…
Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy
Arrhythmogenic right ventricular cardiomyopathy (ARVC), also called arrhythmogenic right ventricular dysplasia or arrhythmogenic cardiomyopathy, is a genetic disease characterised by progressive myocyte loss with replacement by fibrofatty tissue. This structural change leads to the prominent feature...
Autores principales: | Wallace, Ryan, Calkins, Hugh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Radcliffe Cardiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076971/ https://www.ncbi.nlm.nih.gov/pubmed/33936740 http://dx.doi.org/10.15420/aer.2020.39 |
Ejemplares similares
-
Arrhythmogenic right ventricular cardiomyopathy
por: Cho, Yongkeun
Publicado: (2018) -
Arrhythmogenic Mitral Valve Prolapse
por: Korovesis, Theofanis George, et al.
Publicado: (2022) -
Present and Future Perspectives on the Role of Biomarkers in Atherosclerotic Cardiovascular Disease Risk Stratification
por: Gigante, Bruna
Publicado: (2023) -
Arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy
por: Gasperetti, Alessio, et al.
Publicado: (2023) -
Ventricular Arrhythmia in Cancer Patients: Mechanisms, Treatment Strategies and Future Avenues
por: Agarwal, Manyoo A, et al.
Publicado: (2023)